Impact of multi-approach strategy on acid suppressive medication use in a teaching hospital in Qatar

  • Imran F. KhudairEmail author
  • Nagham D. Sadik
  • Yolande Hanssens
  • Saif A. Muhsin
  • Issa Matar
Research Article


Objective To evaluate the impact of a multi-approach strategy to improve the appropriate usage of acid suppressive medication (ASM) in medical inpatients and compare it with the baseline data from 2007. Setting Five general medicine wards in a 600-bed teaching hospital in Doha, Qatar. Method A prospective evaluation of the usage of ASM 1 year after a multi-approach strategy. This consisted of four main interventions: audit and feedback method (including awareness lectures to all medical and pharmacy staff), implementation of a usage guideline for medical inpatients, circulating a logarithmic chart on the proper usage of ASM for medical inpatients from admission through to discharge and participation of clinical pharmacists in the multidisciplinary rounds. All medical patients admitted from May through June 2009 were evaluated. Data about the usage of ASM were collected upon and during admission, at discharge and at the next follow-up visit. Justified indications for its usage were based on the approved product information and on evidence-based literature recommendations. Data were compared with the findings of the baseline clinical audit done 2 years earlier. Main outcome measure The usage of ASM in justified and non-justified indications upon and during admission, at discharge and at the next follow up visit. Results A total of 414 patients were admitted during the study period, 208 patients (50%) received ASM compared to 53% in 2007 (206 patients out of 389). Seventy-four patients (36%) were using ASM upon admission compared to 48 patients (23%) in the 2007 clinical audit. Inappropriate ASM use decreased with 51% during admission (66 to 32%, P < 0.0001), 62% at discharge (34 to 13%, P < 0.0001) and 67% at the next follow up visit (15 to 5%, P = 0.0008). Conclusion Despite the higher number of patients receiving ASM upon admission, the multi-approach strategy used in our institution resulted in a significant improvement in the appropriate usage of ASM in medical inpatients.


Acid suppressive medications Drug use Prescribing intervention Qatar Teaching hospital 



The authors would like to express their sincerest gratitude to the physicians and clinical pharmacists who are taking care of medical patients in HGH and for their valuable support toward the proper usage of ASM in these patients. They particularly thank Dr. Abdul Latif Al Khal, Chairman of Medicine Department and Director of Medical Education at HMC for his continuous support.


This work was supported by the medical research committee of Hamad Medical Corporation through research grant (9034/09).

Conflicts of interest

The authors have no conflicts of interest to declare.


  1. 1.
    Khudair IF, Sadik ND, Hanssens Y. Prescribing pattern of acid suppressive medications for medical inpatients in a teaching hospital in Qatar. Saudi Med. J. 2009;30:125–9.PubMedGoogle Scholar
  2. 2.
    Pham CQ, Regal RE, Bostwick TR, Knauf KS. Acid suppressive therapy use on an inpatient internal medicine service. Ann. Pharmacother. 2006;40:1261–6.PubMedCrossRefGoogle Scholar
  3. 3.
    Heidelbaugh JJ, Inadomi JM. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Am. J. Gastroenterol. 2006;101:2200–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Grube RR, May DB. Stress ulcer prophylaxis in hospitalized patients not in intensive care units. Am. J. Health Syst. Pharm. 2007;64:1396–400.PubMedCrossRefGoogle Scholar
  5. 5.
    Mayet AY. Improper use of antisecretory drugs in a tertiary care teaching hospital: an observational study. Saudi J. Gastroenterol. 2007;13:124–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Sklendar SJ, Culley CM. Collaboratively designed practice guidelines promote appropriate use of intravenous proton pump inhibitors. Hosp. Pharm. 2005;40:497–504.Google Scholar
  7. 7.
    Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K. Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br. J. Clin. Pharmacol. 2010;69:543–52.PubMedCrossRefGoogle Scholar
  8. 8.
    Regal RE, Osta AD, Parekh VI. Interventions to curb the overuse of Acid-suppressive medications on an inpatient general medicine service. P. T. 2010;35:86–90.PubMedGoogle Scholar
  9. 9.
    Smeets HM, Hoes AW, de Wit NJ. Effectiveness and costs of implementation strategies to reduce acid suppressive drug prescriptions: a systematic review. BMC Health Serv. Res. 2007;7:177.PubMedCrossRefGoogle Scholar
  10. 10.
    Ahrens D, Chenot JF, Behrens G, Grimmsmann T, Kochen MM. Appropriateness of treatment recommendations for PPI in hospital discharge letters. Eur. J. Clin. Pharmacol. 2010;66:1265–71.PubMedCrossRefGoogle Scholar
  11. 11.
    Leontiadis GI, Sharma VK, Howden CW. Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding. BMJ. 2005;330:568.PubMedCrossRefGoogle Scholar
  12. 12.
    ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998. Am. J. Health Syst. Pharm. 1999;56:347–79.Google Scholar
  13. 13.
    Skála I, Marecková O, Vítko S, Matl I, Lácha J. Prophylaxis of acute gastroduodenal bleeding after renal transplantation. Transpl. Int. 1997;10:375–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Chen LS, Lin HC, Hwang SJ, Lee FY, Hou MC, Lee SD. Prevalence of gastric ulcer in cirrhotic patients and its relation to portal hypertension. J. Gastroenterol. Hepatol. 1996;11:59–64.PubMedCrossRefGoogle Scholar
  15. 15.
    Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticosteroid use and peptic ulcer disease: role of non steroidal anti-inflammatory drugs. Ann. Intern. Med. 1991;114:735–40.PubMedGoogle Scholar
  16. 16.
    Lanza FL. A guideline for the treatment and prevention of NSAID-induced ulcers Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am. J. Gastroenterol. 1998;93:2037–46.PubMedCrossRefGoogle Scholar
  17. 17.
    Grindrod KA, Patel P, Martin JE. What interventions should pharmacists employ to impact health practitioners’ prescribing practices? Ann. Pharmacother. 2006;40:1546–57.PubMedCrossRefGoogle Scholar
  18. 18.
    The Definition of Clinical Pharmacy. American College of Clinical Pharmacy Available at: Accessed on 3 May 2011.
  19. 19.
    van Vliet EP, Steyerberg EW, Otten HJ, Rudolphus A, Knoester PD, Hoogsteden HC, et al. The effects of guideline implementation for proton pump inhibitor prescription on two pulmonary medicine wards. Aliment. Pharmacol. Ther. 2009;29:213–21.PubMedCrossRefGoogle Scholar
  20. 20.
    Heidelbaugh JJ, Goldberg KL, Inadomi JM. Adverse risks associated with proton pump inhibitors: a systematic review. Gastroenterol. Hepatol. (NY). 2009;5:725–34.Google Scholar
  21. 21.
    Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging. 2003;20:817–32.PubMedCrossRefGoogle Scholar
  22. 22.
    Finley PR, Crismon ML, Rush AJ. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy. 2003;231634–44.Google Scholar
  23. 23.
    Batuwitage BT, Kingham JG, Morgan NE, Bartlett RL. Inappropriate prescribing of proton pump inhibitors in primary care. Postgrad. Med. J. 2007;83:66–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Thomson O’Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst. Rev. 2000;2: CD000409.Google Scholar
  25. 25.
    Thomson O’Brien MA, Oxman AD, Haynes RB, Davis DA, Freemantle N, Harvey EL. Local opinion leaders: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2000;2:CD000125.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  • Imran F. Khudair
    • 1
    Email author
  • Nagham D. Sadik
    • 2
  • Yolande Hanssens
    • 1
  • Saif A. Muhsin
    • 2
  • Issa Matar
    • 2
  1. 1.Department of Clinical Pharmacy, Hamad General HospitalHamad Medical CorporationDohaQatar
  2. 2.Department of Medicine, Hamad General HospitalHamad Medical CorporationDohaQatar

Personalised recommendations